Clinical Trial

The Effect of SAAE on Ventricular Remodeling in PA Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 16, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study aims to assess the effect of superselective adrenal arterial embolization on ventricular remodeling in primary aldosteronism without lateralized aldosterone secretion by comparing it with spironolactone therapy.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-08-12; most recent amendment 2025-05-13.
Status change: Not Yet Recruiting → Recruiting 2022-09-16
Trial Details
NCT Number NCT05501080
Lead Sponsor Second Affiliated Hospital of Nanchang University
Conditions Primary Aldosteronism
Enrollment 112 participants
Start Date 2022-09-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-16